Arnica montana (Granules) Instructions for Use

Marketing Authorization Holder

Boiron (France)

Contact Information

Boiron (France)

ATC Code

V30 (Not assigned)

Dosage Forms

	Arnica montana	Homeopathic granules C5: 4 g tube with granule counter
		Homeopathic granules C9: 4 g tube with granule counter
		Homeopathic granules C15: 4 g tube with granule counter
		Homeopathic granules C30: 4 g tube with granule counter

Dosage Form, Packaging, and Product Composition

Excipients: sucrose, lactose.

4 g – tubes with granule counter (1) – cardboard packs.

Clinical-Pharmacological Group

Single-component homeopathic preparation of plant origin

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

Arnica montana is a perennial plant that grows mainly in mountainous areas.

Chemical composition

• Flavonoids and proanthocyanidins;
• Carotenoids and manganese;
• Phenolic acids (caffeic and chlorogenic);
• Sesquiterpene lactones, mainly helenalin.

The plant components have high biological activity.

• Sesquiterpene lactones provide the plant with anti-inflammatory, anti-ecchymotic, and analgesic properties. Helenalin also has an antiseptic effect;
• Flavonoids and proanthocyanidins have a vasoprotective effect.

Indications

Key symptoms for prescribing the drug

• Bruises;
• Pain;
• Muscle pain;
• Hematomas.

Main cases of clinical application

Traumatology

• Blows, falls, wounds, sports injuries, fractures;
• Hemorrhages;
• Consequences of childbirth, neonatal cephalohematoma;
• Pre- and postoperative patient preparation;
• Post-traumatic pain syndrome.

Muscle weakness

• Consequences of prolonged muscle tension (prolonged muscle strain, post-stress myalgia);
• Hoarseness in voice professionals (lecturers, teachers, singers, speakers) due to vocal cord strain;
• Myalgia caused by stressful situations (mourning, etc.), with a feeling of being “beaten up”.

Otolaryngology

• Consequences of tissue and mucous membrane trauma after manipulations and surgical interventions (tonsillectomy and others);
• Prevention and treatment of nosebleeds.

Hematology

• Petechial manifestations on the skin;
• Subconjunctival hemorrhage;
• Hematomas or ecchymoses;
• Superficial phlebitis and periphlebitis (after studying the etiology to exclude thrombophlebitis or phlebothrombosis);
• Varicose veins, telangiectasias;
• Pain in the lower extremities with varicose veins (the drug is prescribed long-term for up to 6-8 weeks);
• Hematuria (together with Phosphorus) in combination with conventional therapy (the drug is prescribed long-term for up to 6-8 weeks).

Dentistry

• Inflammatory diseases of the oral cavity (including stomatitis, gingivitis);
• Consequences of dental procedures (tooth extraction, dental implantation, and others).

Ophthalmology

• Subconjunctival hemorrhage;
• Retinopathy, age-related macular degeneration.

Arnica montana is used as a vasoprotector*.

Gynecology

• Episiotomy;
• Cesarean section;
• Preparation for childbirth.

Dermatology

• Rosacea with symmetrical location of inflamed areas;
• Couperose.

Dosage Regimen

Sublingually.

The granules should be dissolved in the mouth 30 minutes before meals or 60 minutes after meals.

For children from 0 to 3 years old, the granules are first diluted by shaking in 10-15 ml of water at room temperature and given to drink.

The optimal amount per dose is 5 granules.

Consultation with a doctor is necessary to determine the potency, frequency, and duration of administration.

Adverse Reactions

Not reported to date.

Contraindications

• Individual sensitivity to the drug;
• Lactose intolerance.

Special Precautions

The dosage regimen and frequency of administration are determined by the doctor.

If there is no therapeutic effect within 3 days, or if adverse reactions occur, you should consult a doctor.

Overdose

No information on overdose cases has been received to date.

Drug Interactions

When treating with Arnica montana, it is possible to use other medicines.

Storage Conditions

At a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 5 years.

Dispensing Status

The drug is available without a prescription.

* Zicari D., Rkciotti F., Vingolo E.M., Zicari N. “Valutazione dell’azione angioprotettiva di preparati di Arnica nel trattamento della retinopatia diabetica”, Bottettino di oculistica, anno 71, No. 5, 1992: pp. 841-848.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.